热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Brilliant Violet 605™ anti-mouse CD45.1 Anti
产品名称：
Brilliant Violet 605™ anti-mouse CD45.1 Anti
产品类别：
抗体
产品编号：
110737
产品应用：
110737
[价格]
规格 价格 库存
125µL ￥ 2640 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
SJL mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605? under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
?L sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the ?g size, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume. For immunofluorescent staining using the ?l size, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605? excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

The A20 antibody does not react with leukocytes or?mouse cells expressing the CD45.2 alloantigen. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation3, in vitro blocking of B cell responses1,2, immunohistochemical staining of frozen sections: OCT embedded7 and acetone-fixed4-6 (direct immunofluorescence detection with fluorochrome conjugated A20 was used in (5) and (6)).

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  4. Suzuki K, et al. 2000. Immunity 13:691. (IHC-F)
  5. Werner N, et al. 2002. Arterioscler. Thromb. Vasc. Biol. 22:1567. (IHC-F)
  6. Lessner SM, et al. 2002. Am. J. Pathol. 160:2145. (FC, IHC-F)
  7. Chen CC, et al. 2005. P. Natl. Acad. Sci. USA 102:11408 (IHC-F)
  8. Pascal V, et al. 2007. J. Immunol. 179:1751. (FC)
  9. Mende I, et al. 2006. Blood 107:1383. (IHC-F, FC)
  10. Phan TG, et al. 2007. Nature Immunol. 8:992. (FC)
  11. Wither DR, et al. 2009. J. Immunol. 183:5079. PubMed
  12. Pascal V, et al.2007. J. Immunol. 179:1751. PubMed
  13. Lee SW, et al. 2009. J. Immunol. 182:6753. PubMed
  14. Takada K, et al. 2009. J. Exp Med. 206:2253. PubMed
  15. Beamer CA, et al. 2007. Am. J. Respir. Cell. Mol. Biol. 37:729. (FC) PubMed
  16. Li LX, et al. 2010. J. Immunol. 184:1728. PubMed
  17. Hosoi A, et al. 2008. Cancer Res. 68:3941. (FC) PubMed
  18. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  19. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
  2. Han SJ et al. 2017. Immunity. 47(6):1154-1168 . PubMed
  3. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  4. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  5. Cannons JL, et al. 2021. Cell Rep. 37:109804. PubMed
  6. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  7. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  8. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  9. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  10. Wang H, et al. 2022. Curr Protoc. 2:e446. PubMed
  11. Lu SX, et al. 2021. Cell. . PubMed
  12. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  13. Lam WY et al. 2018. Cell reports. 24(9):2479-2492 . PubMed
  14. Duan L, et al. 2021. Immunity. 54:2256. PubMed
  15. Wagner JA, et al. 2020. Cell Rep. 31:107720. PubMed
  16. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  17. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  18. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  19. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  20. Sinha SR, et al. 2020. Cell Host Microbe. 27:659. PubMed
  21. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  22. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  23. Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
  24. Crauste F, et al. 2017. Cell Syst. 0.379166667. PubMed
  25. Engblom C, et al. 2017. Science. 358:6367. PubMed
  26. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  27. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  28. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  29. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  30. Pai CS, et al. 2020. Immunity. 50(2):477-492. PubMed
  31. Bosteels C, et al. 2020. Immunity. 52(6):1039-1056.e9.. PubMed
  32. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  33. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
RRID
AB_11204076 (BioLegend Cat. No. 110737) AB_2562565 (BioLegend Cat. No. 110738)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.1 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.1 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线